91 related articles for article (PubMed ID: 25338604)
1. [Commonly used cre transgenic mice and their applications in hematopoietic system].
Peng LY; Cheng T; Yuan WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1442-7. PubMed ID: 25338604
[TBL] [Abstract][Full Text] [Related]
2. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow.
Keller P; Payne JL; Tremml G; Greer PA; Gaboli M; Pandolfi PP; Bessler M
J Exp Med; 2001 Sep; 194(5):581-9. PubMed ID: 11535627
[TBL] [Abstract][Full Text] [Related]
3. hCD2-iCre and Vav-iCre mediated gene recombination patterns in murine hematopoietic cells.
Siegemund S; Shepherd J; Xiao C; Sauer K
PLoS One; 2015; 10(4):e0124661. PubMed ID: 25884630
[TBL] [Abstract][Full Text] [Related]
4. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.
Georgiades P; Ogilvy S; Duval H; Licence DR; Charnock-Jones DS; Smith SK; Print CG
Genesis; 2002 Dec; 34(4):251-6. PubMed ID: 12434335
[TBL] [Abstract][Full Text] [Related]
5. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
[TBL] [Abstract][Full Text] [Related]
6. Lineage-specific transgene expression in hematopoietic cells using a Cre-regulated retroviral vector.
Turner VM; Gardam S; Brink R
J Immunol Methods; 2010 Aug; 360(1-2):162-6. PubMed ID: 20600080
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of T cell function and conditional gene targeting in T cells.
Sledzińska A; Fairbairn L; Buch T
Methods Mol Biol; 2014; 1193():153-69. PubMed ID: 25151005
[TBL] [Abstract][Full Text] [Related]
8. Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.
Kilani B; Gourdou-Latyszenok V; Guy A; Bats ML; Peghaire C; Parrens M; Renault MA; Duplàa C; Villeval JL; Rautou PE; Couffinhal T; James C
J Thromb Haemost; 2019 May; 17(5):827-840. PubMed ID: 30801958
[TBL] [Abstract][Full Text] [Related]
9. Labeling of hematopoietic stem and progenitor cells in novel activatable EGFP reporter mice.
Gilchrist DS; Ure J; Hook L; Medvinsky A
Genesis; 2003 Jul; 36(3):168-76. PubMed ID: 12872249
[TBL] [Abstract][Full Text] [Related]
10. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
[TBL] [Abstract][Full Text] [Related]
11. Analyzing gene function in adult long-term hematopoietic stem cells using the interferon inducible Mx1-Cre mouse system.
Gudmundsson KO; Oakley K; Han Y; Du Y
Methods Mol Biol; 2014; 1194():313-25. PubMed ID: 25064111
[TBL] [Abstract][Full Text] [Related]
12. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
[TBL] [Abstract][Full Text] [Related]
13. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
14. Conditional targeting: inducible deletion by Cre recombinase.
O'Neal KR; Agah R
Methods Mol Biol; 2007; 366():309-20. PubMed ID: 17568132
[TBL] [Abstract][Full Text] [Related]
15. The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells.
Tang Y; Harrington A; Yang X; Friesel RE; Liaw L
Genesis; 2010 Sep; 48(9):563-7. PubMed ID: 20645309
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-2 genomic elements drive cre recombinase expression in primitive blood, vascular and neuronal lineages.
Wiszniak S; Scherer M; Ramshaw H; Schwarz Q
Genesis; 2015 Nov; 53(11):709-17. PubMed ID: 26454009
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation as a tracer of off-target Cre-lox activation in development.
Glendenning LM; Reynero KM; Cobb BA
Glycobiology; 2024 Apr; 34(5):. PubMed ID: 38438159
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
Jin C; McKeehan K; Wang F
Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
[TBL] [Abstract][Full Text] [Related]
19. Anomalous baroreflex functionality inherent in floxed and Cre-Lox mice: an overlooked physiological phenotype.
Tsai CY; Poon YY; Chen CH; Chan SHH
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H700-H707. PubMed ID: 28778914
[TBL] [Abstract][Full Text] [Related]
20. Site-specific recombination of asymmetric lox sites mediated by a heterotetrameric Cre recombinase complex.
Saraf-Levy T; Santoro SW; Volpin H; Kushnirsky T; Eyal Y; Schultz PG; Gidoni D; Carmi N
Bioorg Med Chem; 2006 May; 14(9):3081-9. PubMed ID: 16412655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
